Insider transactions

EDGAR

Elevance Health, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-17.

Open-market purchases (code P)
4 transactions, 6,725 shares
Sum of shares × price per share: 2,237,800.05
Open-market sales (code S)
19 transactions, 17,157 shares
Sum of shares × price per share: 6,975,061.75

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 85

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-05 Filed 2026-11-06LAVU RATNAKAR Officer: EVP Chief Digital Info Ofr
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,300440
572,000

Derived: shares × price per share. Exact value 572000.

14,849Direct (D) No
F1
  • F1 This transaction was executed in multiple trades, each at the same price of $440.00.
Open filing 0001737620-26-000005 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)400434
173,600

Derived: shares × price per share. Exact value 173600.

30,103Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $433.54 to $434.33. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)321435.25
139,715.25

Derived: shares × price per share. Exact value 139715.25.

29,782Direct (D) No
F2
  • F2 This transaction was executed in multiple trades at prices ranging from $434.72 to $435.63. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,660436.20
724,092

Derived: shares × price per share. Exact value 724092.00.

28,122Direct (D) No
F3
  • F3 This transaction was executed in multiple trades at prices ranging from $435.76 to $436.69. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)560437.07
244,759.2

Derived: shares × price per share. Exact value 244759.20.

27,562Direct (D) No
F4
  • F4 This transaction was executed in multiple trades at prices ranging from $436.78 to $437.76. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)240438.22
105,172.8

Derived: shares × price per share. Exact value 105172.80.

27,322Direct (D) No
F5
  • F5 This transaction was executed in multiple trades at prices ranging from $437.80 to $438.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,160439.25
509,530

Derived: shares × price per share. Exact value 509530.00.

26,162Direct (D) No
F6
  • F6 This transaction was executed in multiple trades at prices ranging from $438.86 to $439.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,720440.44
757,556.8

Derived: shares × price per share. Exact value 757556.80.

24,442Direct (D) No
F7
  • F7 This transaction was executed in multiple trades at prices ranging from $439.87 to $440.75. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,343441.34
1,034,059.62

Derived: shares × price per share. Exact value 1034059.62.

22,099Direct (D) No
F8
  • F8 This transaction was executed in multiple trades at prices ranging from $440.88 to $441.75. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)480442.61
212,452.8

Derived: shares × price per share. Exact value 212452.80.

21,619Direct (D) No
F9
  • F9 This transaction was executed in multiple trades at prices ranging from $442.16 to $442.83. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)440443.81
195,276.4

Derived: shares × price per share. Exact value 195276.40.

21,179Direct (D) No
F10
  • F10 This transaction was executed in multiple trades at prices ranging from $443.58 to $444.14. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)160444.85
71,176

Derived: shares × price per share. Exact value 71176.00.

21,019Direct (D) No
F11
  • F11 This transaction was executed in multiple trades at prices ranging from $444.65 to $445.09. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)827446.05
368,883.35

Derived: shares × price per share. Exact value 368883.35.

20,192Direct (D) No
F12
  • F12 This transaction was executed in multiple trades at prices ranging from $445.73 to $446.72. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-23Kaye Mark Officer: EVP CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)273447.19
122,082.87

Derived: shares × price per share. Exact value 122082.87.

19,919Direct (D) No
F13
  • F13 This transaction was executed in multiple trades at prices ranging from $447.05 to $447.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001748691-26-000008 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-06Kaye Mark Officer: EVP CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)4,161386.43
1,607,935.23

Derived: shares × price per share. Exact value 1607935.23.

27,876Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001748691-26-000005 Read from the filing’s XML Dispute this row
2026-10-02 Filed 2026-10-06Kaye Mark Officer: EVP CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,6270—30,503Direct (D) No
F2
  • F2 Represents performance based restricted share units. Restrictions lapsed on 10/2/2026.
Open filing 0001748691-26-000005 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Wessling Erin M Officer: EVP Chief Legal Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)255414.78
105,768.9

Derived: shares × price per share. Exact value 105768.90.

7,230Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0002084548-26-000005 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Wessling Erin M Officer: EVP Chief Legal Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)94405.84
38,148.96

Derived: shares × price per share. Exact value 38148.96.

7,485Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0002084548-26-000005 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-04Craig Ryan R Officer: EVP Chief HR Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)144405.84
58,440.96

Derived: shares × price per share. Exact value 58440.96.

6,530Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0002084547-26-000009 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17BOUDREAUX GAIL Director · Officer: President and CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)680366.41
249,158.8

Derived: shares × price per share. Exact value 249158.80.

169,931Direct (D) No
F1
  • F1 This transaction was executed in multiple purchases at prices ranging from $366.14 to $366.48. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001287920-26-000006 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17BOUDREAUX GAIL Director · Officer: President and CEO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,045368.25
753,071.25

Derived: shares × price per share. Exact value 753071.25.

171,976Direct (D) No
F2
  • F2 This transaction was executed in multiple purchases at prices ranging from $367.76 to $368.69. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001287920-26-000006 Read from the filing’s XML Dispute this row
2026-07-17 Filed 2026-07-17PERU RAMIRO G Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,000366.05
366,050

Derived: shares × price per share. Exact value 366050.00.

10,908Direct (D) No— Open filing 0001192045-26-000004 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-15Penczek Ronald W Officer: CAO Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)369403.16
148,766.04

Derived: shares × price per share. Exact value 148766.04.

3,740Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $403.15 to $403.31. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001659075-26-000006 Read from the filing’s XML Dispute this row
2026-06-11 Filed 2026-06-12Dixon Robert L JR Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)151401.77
60,667.27

Derived: shares × price per share. Exact value 60667.27.

10,734Direct (D) No— Open filing 0001524849-26-000004 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Penczek Ronald W Officer: CAO Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)654271.27
177,410.58

Derived: shares × price per share. Exact value 177410.58.

4,763Direct (D) No
F1
  • F1 Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan.
Open filing 0001659075-26-000004 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Penczek Ronald W Officer: CAO Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)877311.48
273,167.96

Derived: shares × price per share. Exact value 273167.96.

5,640Direct (D) No— Open filing 0001659075-26-000004 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Penczek Ronald W Officer: CAO Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,531403.13
617,192.03

Derived: shares × price per share. Exact value 617192.03.

4,109Direct (D) No
F2
  • F2 This transaction was executed in multiple trades, each at the same price of $403.13.
Open filing 0001659075-26-000004 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Penczek Ronald W Officer: CAO Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (654) — exercise price 271.27
Disposed (D)6540—0Direct (D) No
F3
  • F3 Fully vested.
Open filing 0001659075-26-000004 Read from the filing’s XML Dispute this row
2026-05-19 Filed 2026-05-20Penczek Ronald W Officer: CAO Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (877) — exercise price 311.48
Disposed (D)8770—0Direct (D) No
F3
  • F3 Fully vested.
Open filing 0001659075-26-000004 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15Jallal Bahija Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—5,351Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001730038-26-000004 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15Neri Antonio F Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—5,488Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001648401-26-000006 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15DeVore Susan D. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—4,065Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001587697-26-000006 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15HAY LEWIS III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—12,070Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001182705-26-000004 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15COLLIS STEVEN H Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—4,202Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001191508-26-000004 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15SCHULMAN AMY W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—781Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001438226-26-000009 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15PERU RAMIRO G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—9,908Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001192045-26-000002 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15STRABLE-SOETHOUT DEANNA D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—2,209Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001628280-26-035643 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15Dixon Robert L JR Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—10,885Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001524849-26-000002 Read from the filing’s XML Dispute this row
2026-05-13 Filed 2026-05-15Schneider Ryan M. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5630—7,163Direct (D) No
F1, F2
  • F1 Deferred stock units accrued under the Elevance Health, Inc. (Company) Board of Directors Compensation Program.
  • F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.
Open filing 0001420501-26-000004 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-23SCHULMAN AMY W Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)26287.50
7,475

Derived: shares × price per share. Exact value 7475.00.

218Direct (D) No— Open filing 0001438226-26-000007 Read from the filing’s XML Dispute this row
2026-03-06 Filed 2026-03-09Kendrick Charles Morgan JR Officer: EVP President, Commercial
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,196284.92
910,604.32

Derived: shares × price per share. Exact value 910604.32.

11,791Direct (D) No
F1
  • F1 This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open filing 0001887908-26-000005 Read from the filing’s XML Dispute this row
2026-03-05 Filed 2026-03-06COLLIS STEVEN H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,000289.84
869,520

Derived: shares × price per share. Exact value 869520.00.

3,639Direct (D) No— Open filing 0001191508-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Kendrick Charles Morgan JR Officer: EVP President, Commercial
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)467284.03
132,642.01

Derived: shares × price per share. Exact value 132642.01.

14,987Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001887908-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Kaye Mark Officer: EVP CFO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)353284.03
100,262.59

Derived: shares × price per share. Exact value 100262.59.

32,037Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001748691-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Haytaian Peter D Officer: EVP Pres Carelon CarelonRx
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)446284.03
126,677.38

Derived: shares × price per share. Exact value 126677.38.

27,222Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001608538-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Craig Ryan R Officer: EVP Chief HR Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)309284.03
87,765.27

Derived: shares × price per share. Exact value 87765.27.

6,674Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0002084547-26-000005 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04BOUDREAUX GAIL Director · Officer: President and CEO
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)1,736284.03
493,076.08

Derived: shares × price per share. Exact value 493076.08.

169,251Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001287920-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Norwood Felicia F Officer: EVP Chief Health Benefits Ofr
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)496284.03
140,878.88

Derived: shares × price per share. Exact value 140878.88.

38,838Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001743548-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04Wessling Erin M Officer: EVP Chief Legal Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)417284.03
118,440.51

Derived: shares × price per share. Exact value 118440.51.

7,579Direct (D) No
F2
  • F2 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0002084548-26-000002 Read from the filing’s XML Dispute this row
2026-03-03 Filed 2026-03-04LAVU RATNAKAR Officer: EVP Chief Digital Info Ofr
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)222284.03
63,054.66

Derived: shares × price per share. Exact value 63054.66.

16,149Direct (D) No
F1
  • F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
Open filing 0001737620-26-000002 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-16. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–50 of 1,676

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager19,523,886 SH7,591,277,244 dollarsHigher by 532,796 Prior quarter: 18,991,090Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 13,823,409 SH5,374,817,887 dollarsLower by 234,795 Prior quarter: 14,058,204Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager10,493,831 SH4,080,211,369 dollarsHigher by 67,221 Prior quarter: 10,426,610Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager8,516,420 SH3,311,354,424 dollarsLower by 697,093 Prior quarter: 9,213,513Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 6,204,274 SH2,412,345,817 dollarsLower by 10,082 Prior quarter: 6,214,356Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Sanders Capital, LLC 5,830,605 SH2,267,055,836 dollarsHigher by 5,581 Prior quarter: 5,825,024Open filing 0001172661-26-004809 Filed 2026-11-02 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager5,216,506 SH2,019,246,207 dollarsHigher by 50,382 Prior quarter: 5,166,124Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Invesco Ltd. Partly reported under another manager5,068,202 SH1,970,618,428 dollarsHigher by 833,971 Prior quarter: 4,234,231Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
HARRIS ASSOCIATES L P Partly reported under another manager4,778,654 SH1,858,036,272 dollarsLower by 145,857 Prior quarter: 4,924,511Open filing 0000813917-26-000049 Filed 2026-11-16 Dispute this row
First Eagle Investment Management, LLC Partly reported under another manager4,198,657 SH1,632,521,706 dollarsLower by 4,177,735 Prior quarter: 8,376,392Open filing 0001325447-26-000037 Filed 2026-11-10 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager3,876,188 SH1,507,140 dollarsLower by 138,803 Prior quarter: 4,014,991Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Artisan Partners Limited Partnership 3,763,408 SH1,463,288,299 dollarsLower by 817,814 Prior quarter: 4,581,222Open filing 0001466153-26-000009 Filed 2026-11-13 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager3,445,545 SH1,339,696,599 dollarsHigher by 222,758 Prior quarter: 3,222,787Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Nuveen, LLC Partly reported under another manager3,051,056 SH1,186,311,466 dollarsHigher by 1,061,193 Prior quarter: 1,989,863Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager2,683,515 SH1,043,404,290 dollarsHigher by 877,248 Prior quarter: 1,806,267Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager2,629,543 SH1,022,420,600 dollarsHigher by 23,779 Prior quarter: 2,605,764Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager2,370,165 SH921,567,674 dollarsLower by 761,487 Prior quarter: 3,131,652Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager2,307,508 SH897,205,261 dollarsHigher by 192,522 Prior quarter: 2,114,986Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CITIGROUP INC Partly reported under another manager2,062,306 SH801,865,798 dollarsLower by 34,557 Prior quarter: 2,096,863Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager1,982,407 SH770,799,493 dollarsLower by 83,130 Prior quarter: 2,065,537Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
HOTCHKIS WILEY CAPITAL MANAGEMENT LLC 1,966,986 SH764,803,497 dollarsLower by 49,214 Prior quarter: 2,016,200Open filing 0001172661-26-005357 Filed 2026-11-16 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager1,825,294 SH706,753,844 dollarsHigher by 1,399,134 Prior quarter: 426,160Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
Legal General Group Plc Partly reported under another manager1,800,172 SH699,942,874 dollarsHigher by 19,940 Prior quarter: 1,780,232Open filing 0001495115-26-000075 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,799,384 SH699,636,615 dollarsLower by 4,319 Prior quarter: 1,803,703Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
VICTORY CAPITAL MANAGEMENT INC Partly reported under another manager1,701,589 SH661,611,835 dollarsHigher by 1,080,331 Prior quarter: 621,258Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager1,694,061 SH659,412,436 dollarsLower by 241,819 Prior quarter: 1,935,880Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row
Grantham, Mayo, Van Otterloo Co. LLC 1,678,831 SH652,764,153 dollarsLower by 12,840 Prior quarter: 1,691,671Open filing 0001072613-26-000864 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager1,546,951 SH601,538,919 dollarsLower by 7,408 Prior quarter: 1,554,359Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,412,469 SH549,196,190 dollarsLower by 593,144 Prior quarter: 2,005,613Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
EAGLE CAPITAL MANAGEMENT LLC 1,411,037 SH548,639,270 dollarsLower by 80,372 Prior quarter: 1,491,409Open filing 0001172661-26-005392 Filed 2026-11-16 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,396,622 SH548,496,305 dollarsHigher by 399,408 Prior quarter: 997,214Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager1,367,488 SH531,706,684 dollarsLower by 160,928 Prior quarter: 1,528,416Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row
BAUPOST GROUP LLC/MA 1,275,154 SH495,805 dollarsUnchanged Prior quarter: 1,275,154Open filing 0001061768-26-000015 Filed 2026-11-13 Dispute this row
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Partly reported under another manager1,240,820 SH482,455,632 dollarsLower by 82,343 Prior quarter: 1,323,163Open filing 0001164508-26-000060 Filed 2026-11-13 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager1,221,296 SH474,809 dollarsHigher by 68,947 Prior quarter: 1,152,349Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,198,292 SH465,919,895 dollarsHigher by 4,956 Prior quarter: 1,193,336Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager1,055,208 SH458,150,211 dollarsHigher by 122,168 Prior quarter: 933,040Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
BAILLIE GIFFORD CO Partly reported under another manager1,036,700 SH403,089,694 dollarsLower by 46,537 Prior quarter: 1,083,237Open filing 0001088875-26-000074 Filed 2026-11-09 Dispute this row
Amundi Partly reported under another manager1,011,757 SH393,391,374 dollarsLower by 632,780 Prior quarter: 1,644,537Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager990,257 SH385,031,728 dollarsHigher by 47,203 Prior quarter: 943,054Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Ruane, Cunniff Goldfarb L.P. 974,621 SH378,952,137 dollarsLower by 4,977 Prior quarter: 979,598Open filing 0000919574-26-007856 Filed 2026-11-16 Dispute this row
1832 Asset Management L.P. 972,022 SH377,941,594 dollarsHigher by 53,785 Prior quarter: 918,237Open filing 0000944388-26-000018 Filed 2026-11-10 Dispute this row
Newport Trust Company, LLC 927,194 SH360,511,571 dollarsLower by 27,721 Prior quarter: 954,915Open filing 0001172661-26-004966 Filed 2026-11-12 Dispute this row
ACR Alpine Capital Research, LLC Partly reported under another manager919,031 SH357,337,442 dollarsHigher by 181,109 Prior quarter: 737,922Open filing 0001508822-26-000008 Filed 2026-11-02 Dispute this row
Capital International Investors Partly reported under another manager753,767 SH293,079,877 dollarsHigher by 1,995 Prior quarter: 751,772Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row
Allianz Asset Management GmbH Partly reported under another manager739,616 SH287,577,493 dollarsHigher by 183,479 Prior quarter: 556,137Open filing 0001193125-26-463640 Filed 2026-11-16 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager671,321 SH261,442,044 dollarsHigher by 116,000 Prior quarter: 555,321Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
High Ground Investment Management LLP 663,949 SH258,156,650 dollarsLower by 15,955 Prior quarter: 679,904Open filing 0001828180-26-000005 Filed 2026-11-06 Dispute this row
National Pension Service 599,630 SH233,148,137 dollarsHigher by 9,917 Prior quarter: 589,713Open filing 0001193125-26-456954 Filed 2026-11-12 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager598,854 SH232,848,085 dollarsLower by 55,395 Prior quarter: 654,249Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORGES BANK 3,958,856 SH
  • Sixth Street Partners Management Company, L.P. 1,803,703 SH
  • SG Americas Securities, LLC 1,372,089 SH
  • Veritas Asset Management LLP 428,672 SH
  • Jupiter Topco LLC 394,480 SH
  • INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 300,065 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 242,302 SH
  • TWO SIGMA INVESTMENTS, LP 162,061 SH
  • WORLDQUANT MILLENNIUM ADVISORS LLC 143,876 SH
  • ORBIMED ADVISORS LLC 114,700 SH
  • Ilex Capital Partners (UK) LLP 113,556 SH
  • Tredje AP-fonden 97,645 SH
  • HRT FINANCIAL LP 89,698 SH
  • GLENVIEW CAPITAL MANAGEMENT, LLC 66,599 SH
  • SRS Investment Management, LLC 61,945 SH
  • Integral Health Asset Management, LLC 50,000 SH
  • SG Americas Securities, LLC 50,000 SH
  • AUXIER ASSET MANAGEMENT LLC 35,687 SH
  • Rhenman Partners Asset Management AB 34,900 SH
  • Cornerstone Advisors, LLC 34,721 SH
  • World Investment Advisors 29,719 SH
  • Generate Investment Management Ltd 25,518 SH
  • Channing Capital Management, LLC 24,561 SH
  • IEQ CAPITAL, LLC 20,105 SH
  • CAPITAL FUND MANAGEMENT S.A. 19,200 SH
  • Walleye Trading LLC 19,000 SH
  • Pacer Advisors, Inc. 18,723 SH
  • DIVERSIFIED TRUST CO 17,694 SH
  • BARCLAYS PLC 17,500 SH
  • GCM Grosvenor Holdings, LLC 16,983 SH
  • Verition Fund Management LLC 16,138 SH
  • Brevan Howard Capital Management LP 15,904 SH
  • COBALT CAPITAL MANAGEMENT, INC. 15,000 SH
  • Kentucky Retirement Systems 14,043 SH
  • Sone Capital Management, LLC 13,292 SH
  • Connor, Clark Lunn Investment Management Ltd. 13,203 SH
  • CAPITAL FUND MANAGEMENT S.A. 12,800 SH
  • Holocene Advisors, LP 12,293 SH
  • D. E. Shaw Co., Inc. 11,500 SH
  • Neo Ivy Capital Management 10,922 SH
  • Walleye Trading LLC 10,700 SH
  • GREENUP STREET WEALTH MANAGEMENT LLC 10,269 SH
  • PARUS FINANCE (UK) Ltd 10,148 SH
  • ORBIMED ADVISORS LLC 10,000 SH
  • Caption Management, LLC 9,700 SH
  • TWIN CITY PRIVATE WEALTH, LLC 9,187 SH
  • Campbell CO Investment Adviser LLC 9,122 SH
  • Twin Tree Management, LP 8,900 SH
  • GROUPAMA ASSET MANAGMENT 8,892 SH
  • Envestnet Portfolio Solutions, Inc. 8,619 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock7.1316,601,22403/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000451 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 11Open filing 0000102909-26-001129 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,225,847 filings read, dated 2004-06-14 to 2026-11-16: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
2022143,589
2023199,811
2024209,823
2025235,520
2026260,165

Filings made before the SEC required XML are listed, not extracted.

Back to Elevance Health, Inc.